TrialPLoS neglected tropical diseases2023

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.

Nicholas O Opoku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.